Elevance Health, Inc. (ELV)

Elevance Health Stock Forecast

Stock Price Forecast

The 18 analysts that cover Elevance Health stock have a consensus rating of "Buy" and an average price target of $383.56, which forecasts a 1.84% increase in the stock price over the next year. The lowest target is $310 and the highest is $478.

Price Target: $383.56 (+1.84%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$310	$383.56	$391	$478
Change	-17.69%	+1.84%	+3.82%	+26.92%

Analyst Ratings

The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	6
Buy	6	6	7	7	7	6
Hold	6	7	7	7	7	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	17	18	18	18	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kevin Fischbeck B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $405 → $435	Hold → Strong Buy	Upgrades	$405 → $435	+15.50%	Apr 29, 2026
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $397 → $411	Buy	Maintains	$397 → $411	+9.13%	Apr 28, 2026
Andrew Mok Barclays	Barclays	Buy Maintains $393 → $408	Buy	Maintains	$393 → $408	+8.33%	Apr 24, 2026
Jason Cassorla Guggenheim	Guggenheim	Strong Buy Maintains $396 → $399	Strong Buy	Maintains	$396 → $399	+5.94%	Apr 24, 2026
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Hold Maintains $345 → $360	Hold	Maintains	$345 → $360	-4.42%	Apr 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

194.84B

Decreased by -2.15%

from 199.13B

Revenue Next Year

200.82B

Increased by 3.07%

from 194.84B

EPS This Year

26.17

Increased by 3.82%

from 25.21

EPS Next Year

29.55

Increased by 12.89%

from 26.17

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	138.64B	156.60B	171.34B	176.81B	199.13B	194.84B	200.82B
Revenue Growth	13.77%	12.95%	9.41%	3.19%	12.62%	-2.15%	3.07%
EPS	24.95	24.28	25.22	25.68	25.21	26.17	29.55
EPS Growth	38.77%	-2.69%	3.87%	1.82%	-1.83%	3.82%	12.89%
Forward PE	-	-	-	-	-	14.39	12.75
No. Analysts	-	-	-	-	-	25	23

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	215.1B	220.5B
Avg	194.8B	200.8B
Low	183.3B	190.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	8.0%	13.2%
Avg	-2.2%	3.1%
Low	-8.0%	-2.3%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	29.42	33.62
Avg	26.17	29.55
Low	24.90	27.81

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	16.7%	28.5%
Avg	3.8%	12.9%
Low	-1.2%	6.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.